CELL & GENE: THE PODCAST

38:12 23_12_CGPodcast_1280x720_Ep101
CRI's Response to NIH Cuts with Alicia Zhou, Ph.D.

In this episode of the Cell & Gene podcast, Host Erin Harris speaks with Alicia Zhou, Ph.D., CEO of the Cancer Research Institute (CRI), about CRI’s mission to advance cancer immunotherapy and the critical role of federal funding, particularly from the NIH, in s...

THE VOICES OF A BURGEONING MARKET

Cell & Gene, the most valuable resource for delivering in-depth content from authoritative authors and sources to professionals in the CGT sector, brings you Cell & Gene: The Podcast. Each episode explores approved and pipeline therapies, new trends in manufacturing, the long, regulated road to commercialization, and everything in between.

FEATURED GUESTS

Alicia Zhou
CRI
PLAY
Audrey Greenberg
AG Capital Advisors
PLAY
Kenji Fujita
Atsena Therapeutics
PLAY
Simrit Parmar
Cellenkos
PLAY
Omkar Kawalekar
Deloitte Consulting
PLAY
Faraz Ali
Tenaya Therapeutics
PLAY
Helen Sabzevari
Precigen
PLAY
Christopher Horan
Artiva Biotherapeutics
PLAY
Christopher Choi
Roswell Park Comprehensive Cancer Center
PLAY
Lothar Roessig
Asklepios BioPharmaceutical
PLAY
Amit Rahkit
BlueRock Therapeutics
PLAY
Rita Johnson-Greene
Alliance for Regenerative Medicine
PLAY
Dennis Williams
Adaptimmune
PLAY
Miguel Forte
Kiji Therapeutics
PLAY
Carsten Linnemann
Neogene Therapeutics
PLAY
Paul Bresge
Ray Therapeutics
PLAY
Michael Severino
Tessera Therapeutics
PLAY
Zachary Roberts
Allogene Therapeutics
PLAY
Debra Miller
CureDuchenne
PLAY
Michael Kelly
CureDuchenne
PLAY
Lucas Harrington
Mammoth Biosciences
PLAY
Micah Benson
KSQ Therapeutics
PLAY
Aki Ko
Elixirgen Therapeutics
PLAY
Bambi Grilley
ISCT
PLAY
Bruce Levine
University of Pennsylvania
PLAY
Ahmed Enayetallah
Dompé
PLAY
Robert Ang
Vor Bio
PLAY
Scott McClellan
Orca Bio
PLAY
Sharon Rosenzweig-Lipson
Life Biosciences
PLAY
Cat Lutz
The Jackson Laboratory
PLAY
Peter Marks
FDA
PLAY
Karen Kozarsky
SwanBio Therapeutics
PLAY
Rachelle Jacques
Akari Therapeutics
PLAY
Apple Spotify   YouTube

MEET YOUR HOST

Erin HarrisHosted by Cell & Gene Chief Editor Erin Harris, Cell & Gene: The Podcast interviews industry and academic leaders on what they’re working on and how it's moving the sector forward.

LINKEDIN

Interested in joining us on air? Contact us

RECENT EPISODES

38:12 23_12_CGPodcast_1280x720_Ep101

CRI's Response to NIH Cuts with Alicia Zhou, Ph.D.

28:15 23_12_CGPodcast_1280x720_Ep100

Rethinking CGT Biotech Growth & Investment with Audrey Greenberg

14:53 23_12_CGPodcast_1280x720_Ep99

Advancing Retinal Gene Therapy with Atsena Therapeutics' Dr. Kenji Fujita

34:57 23_12_CGPodcast_1280x720_Ep98

Harnessing the Power of Cord Blood Tregs with Cellenkos' Dr. Simrit Parmar

28:42 23_12_CGPodcast_1280x720_Ep97

CGT Manufacturing: Distributed & Digital with Deloitte Consulting's Omkar Kawalekar, Ph.D.

35:38 23_12_CGPodcast_1280x720_Ep96

Inside Gene Therapies for Cardiac Care with Tenaya Therapeutics' Faraz Ali

26:49 23_12_CGPodcast_1280x720_Ep95

The Future of Adenovector-Based Therapies with Precigen's Helen Sabzevari, Ph.D.

24:24 23_12_CGPodcast_1280x720_Ep94

The Future of NK Cell Therapy for Autoimmune Disease with Artiva Biotherapeutics' Christopher Horan

14:49 23_12_CGPodcast_1280x720_Ep93

Lessons in Automation with Roswell Park Comprehensive Cancer Center's Christopher Choi, Ph.D.

21:08 23_12_CGPodcast_1280x720_Ep92

Can Gene Therapy Be The Solution For CHF With AskBio's Dr. Lothar Roessig

31:14 23_12_CGPodcast_1280x720_Ep91

Inside A Dopamine-Restoring Cell Therapy For PD With BlueRock Therapeutics' Dr. Amit Rakhit

21:39 23_12_CGPodcast_1280x720_Ep90

Globalization's Impact on Patient Access with ARM's COO, Rita Johnson-Greene

20:52 23_12_CGPodcast_1280x720_Ep89

Improving TCR T-Cell Persistence and Efficacy with Adaptimmune's Dennis Williams

25:26 23_12_CGPodcast_1280x720_Ep88

Live from ARM's Meeting on the Mesa with Kiji Therapeutics' Dr. Miguel Forte

14:18 23_12_CGPodcast_1280x720_Ep87

Pioneering Next-Gen TCR Therapies In Solid Tumors With Neogene Therapeutics' Carsten Linnemann, Ph.D.

22:00 23_12_CGPodcast_1280x720_Ep86

Optogenetics for Vision Restoration with Ray Therapeutics' Paul Bresge

28:06 23_12_CGPodcast_1280x720_Ep85

A New Approach to Genome Engineering with Tessera Therapeutics' Dr. Michael Severino

25:13 23_12_CGPodcast_1280x720_Ep84

Scaling Allo with Allogene Therapeutics' Dr. Zachary Roberts

27:58 23_12_CGPodcast_1280x720_Ep83

CGT Regulatory Update and Outlook with Dark Horse Consulting's Kimberly Benton, Ph.D.

29:55 23_12_CGPodcast_1280x720_Ep82

Identifying Drug Development Opportunities For DMD With CureDuchenne

21:01 23_12_CGPodcast_1280x720_Ep81

Tackling 'The Delivery Problem' Of Gene Editing-Based Medicines

35:29 23_12_CGPodcast_1280x720_Ep80

TILs for the Treatment of Solid Tumors with KSQ Therapeutics' Micah Benson, Ph.D.

14:52 23_12_CGPodcast_1280x720_Ep78

Developing an mRNA Therapy for DMD with Elixirgen Therapeutics' Aki Ko

25:21 23_12_CGPodcast_1280x720_Ep77

The Current State of the Global Regulatory Landscape with ISCT's Dr. Bambi Grilley

31:48 23_12_CGPodcast_1280x720_Ep76

Dr. Bruce Levine on ISCT and the Future of CAR-T

18:50 23_12_CGPodcast_1280x720_Ep75

CGTs for HIV Suppression with Addimmune's Dr. Marcus Conant

29:39 23_12_CGPodcast_1280x720_Ep74

Inside BlueRock Therapeutics' Parkinson's Disease Trial with Dr. Ahmed Enayetallah

23:08 23_12_CGPodcast_1280x720_Ep73

Reducing the Disease Burden of AML with Vor Bio's Dr. Robert Ang

19:37 23_12_CGPodcast_1280x720_Ep72

Reducing Toxicities in Allogeneic Cell Therapies with Orca Bio's Dr. Scott McClellan

17:17 23_12_CGPodcast_1280x720_Ep71

Inside Cellular Rejuvenation Therapies for Age-Related Diseases with Life Biosciences' Sharon Rosenzweig-Lipson, Ph.D.

27:31 23_12_CGPodcast_1280x720_Ep70

The Future of Rare Diseases with The Jackson Laboratory's Rare Disease Translational Center's Cat Lutz

20:48 23_12_CGPodcast_1280x720_Ep69

Inside Yescarta's Reduced Median Turnaround Time with Kite, a Gilead Company's Christopher McDonald

37:17 23_12_CGPodcast_1280x720_Ep68

Pricing, Value, And Access of CGTs With The Dedham Group's Jennifer Klarer, M.Sc.Eng.

21:33 23_12_CGPodcast_1280x720_Ep67

Breaking Down Solid Tumors With Triumvira Immunologics' Dr. Paul Lammers

31:59 23_12_CGPodcast_1280x720_Ep66

4 Keys To Allo In 2024 With Poseida Therapeutics' Kristin Yarema, Ph.D.

17:23 21_06_Cell&GeneThePodcast_Video_Ep64

Overcoming The Limitations Of CAR T-Cell Therapy With Vittoria Bio's Nick Siciliano, Ph.D.

28:34 21_06_Cell&GeneThePodcast_Video_Ep62

The Promise Of AAV Gene Therapy With REGENXBIO's Ken Mills

18:15 21_06_Cell&GeneThePodcast_Video_Ep60

The Future Of Cell And Organ Transplantation In Treating T1D With Dr. Camillo Ricordi

30:37 21_06_Cell&GeneThePodcast_Video_Ep59

In Vivo CAR T-Cell Therapeutics With Umoja Biopharma's Dr. Andrew Scharenberg

25:17 21_06_Cell&GeneThePodcast_Video_Ep58

Inside Genome Editing With CBER's Dr. Peter Marks

25:53 21_06_Cell&GeneThePodcast_Video_Ep57

The Future Of CAR-T With Bristol Myers Squibb's Lynelle Hoch

23:21 21_06_Cell&GeneThePodcast_Video_Ep56

The Promise Of Genome Editing With Caribou Biosciences' Rachel Haurwitz, Ph.D.

29:16 21_06_Cell&GeneThePodcast_Video_Ep54

The Intersection Of RNA, AI, And Synthetic Biology With Shape Therapeutics' Dr. Francois Vigneault

24:34 21_06_Cell&GeneThePodcast_Video_Ep53

Inside Prime Editing With Prime Medicine's Dr. Andrew Anzalone

27:37 21_06_Cell&GeneThePodcast_Video_Ep51

Dr. Usman "Oz" Azam Discusses The State Cell And Gene Therapy Space

23:45 21_06_Cell&GeneThePodcast_Video_Ep50

Targeting Oncogenic Drivers for Solid Tumor Cancers with Affini-T Therapeutics' Dr. Jak Knowles

42:20 21_06_Cell&GeneThePodcast_Video_Ep49

TJU's Jefferson Institute for Bioprocessing's Impact on CGT with Parviz Shamlou

31:57 21_06_Cell&GeneThePodcast_Video_Ep48

Computational Biology's Role In Gene Therapy With Kriya Therapeutics' Dr. Shankar Ramaswamy

28:17 21_06_Cell&GeneThePodcast_Video_Ep47

The Near-Term Future Of Exosome Science With Capricor Therapeutics' Dr. Linda Marbán

40:51 21_06_Cell&GeneThePodcast_Video_Ep46

Inside The World's First-Ever Allogeneic Approval With Atara Biotherapeutics' Pascal Touchon

20:40 21_06_Cell&GeneThePodcast_Video_Ep45

The Potential Of RNA Exon Editing With Ascidian Therapeutics' Romesh Subramanian, Ph.D.

31:52 21_06_Cell&GeneThePodcast_Video_Ep44

Automating Processes To Scale CGT Manufacturing With PA Consulting's Paolo Siciliano

21:42 21_06_Cell&GeneThePodcast_Video_Ep43

The Why Behind In-House Manufacturing With Sangamo's Andy Ramelmeier

26:34 21_06_Cell&GeneThePodcast_Video_Ep42

2023 Market Outlook with AdBio and ISCT's Miguel Forte

36:05 21_06_Cell&GeneThePodcast_Video_Ep41

CMC And Scale Up With Mustang Bio's Robert Sexton

28:34 22_01_C&GPodcast_1280x720_ep40

An Interview with Dr. Peter Marks

26:57 22_01_C&GPodcast_1280x720_Ep39

Inside NK and Macrophage Cellular Immunotherapies

28:35 21_06_Cell&GeneThePodcast_Video_Ep38

The Future Of iPSCs With BlueRock Therapeutics' CEO Seth Ettenberg

36:45 21_06_Cell&GeneThePodcast_Video_Ep37

Manufacturing at the Point of Care with Orgenesis' CEO Vered Caplan

40:25 21_06_Cell&GeneThePodcast_Video_Ep36

Capstan Therapeutics' CEO Laura Shawver On In Vivo Cell Engineering

32:43 21_06_Cell&GeneThePodcast_Video_Ep33

Inside RNAi With Arrowhead Pharmaceuticals' Javier San Martin

22:48 21_06_cell_genethepodcast_video_ep32

Planning For Manufacturing Capacity With Kite Pharma's Will Junker

19:55 22_01_cgpodcast_1200x628_ep31

Commercialization Learnings With Novartis Gene Therapies' President Chris Fox

27:40 22_01_cgpodcast_1200x628_ep30

A Stem Cell-Derived Treatment For T1D

27:42 22_07_CellGeneThePodcast_YouTubeThumbnail_ep28

An Interview With Dr. Carl June

28:24 21_06_CellGeneThePodcast_Video_Ep29

Best Practices For Partnering With A CDMO

18:50 22_01_CGPodcast_1200x628_Ep18

Restoration of Immune Balance with Anish Suri, Ph.D., President and CSO at Cue Biopharma

20:15 21_06_CGPodcast_1200x628_Ep6.2

Gene Therapies For Spinal Cord-Related Disorders With SwanBio's CSO

30:23 21_06_CGPodcast_1200x628_Ep2

Hospital Systems & Complex Therapies With University Of Pennsylvania Health System's Kevin Mahoney

25:55 21_06_CGPodcast_1200x628_Ep4

State-of-the-Art GMP Manufacturing RNA Cell Therapies With Cartesian's CEO

24:15 The Future of Tissue-Based Therapies

The Future of Tissue-Based Therapies

More Recent Episodes

CLINICAL TRIALS

25:26 23_12_CGPodcast_1280x720_Ep88

Live from ARM's Meeting on the Mesa with Kiji Therapeutics' Dr. Miguel Forte

23:45 21_06_Cell&GeneThePodcast_Video_Ep50

Targeting Oncogenic Drivers for Solid Tumor Cancers with Affini-T Therapeutics' Dr. Jak Knowles

20:52 23_12_CGPodcast_1280x720_Ep89

Improving TCR T-Cell Persistence and Efficacy with Adaptimmune's Dennis Williams

29:39 23_12_CGPodcast_1280x720_Ep74

Inside BlueRock Therapeutics' Parkinson's Disease Trial with Dr. Ahmed Enayetallah

22:00 23_12_CGPodcast_1280x720_Ep86

Optogenetics for Vision Restoration with Ray Therapeutics' Paul Bresge

21:08 23_12_CGPodcast_1280x720_Ep92

Can Gene Therapy Be The Solution For CHF With AskBio's Dr. Lothar Roessig

18:50 23_12_CGPodcast_1280x720_Ep75

CGTs for HIV Suppression with Addimmune's Dr. Marcus Conant

38:12 23_12_CGPodcast_1280x720_Ep101

CRI's Response to NIH Cuts with Alicia Zhou, Ph.D.

40:25 21_06_Cell&GeneThePodcast_Video_Ep36

Capstan Therapeutics' CEO Laura Shawver On In Vivo Cell Engineering

25:13 23_12_CGPodcast_1280x720_Ep84

Scaling Allo with Allogene Therapeutics' Dr. Zachary Roberts

34:57 23_12_CGPodcast_1280x720_Ep98

Harnessing the Power of Cord Blood Tregs with Cellenkos' Dr. Simrit Parmar

28:06 23_12_CGPodcast_1280x720_Ep85

A New Approach to Genome Engineering with Tessera Therapeutics' Dr. Michael Severino

19:37 23_12_CGPodcast_1280x720_Ep72

Reducing Toxicities in Allogeneic Cell Therapies with Orca Bio's Dr. Scott McClellan

23:08 23_12_CGPodcast_1280x720_Ep73

Reducing the Disease Burden of AML with Vor Bio's Dr. Robert Ang

29:16 21_06_Cell&GeneThePodcast_Video_Ep54

The Intersection Of RNA, AI, And Synthetic Biology With Shape Therapeutics' Dr. Francois Vigneault

35:38 23_12_CGPodcast_1280x720_Ep96

Inside Gene Therapies for Cardiac Care with Tenaya Therapeutics' Faraz Ali

14:18 23_12_CGPodcast_1280x720_Ep87

Pioneering Next-Gen TCR Therapies In Solid Tumors With Neogene Therapeutics' Carsten Linnemann, Ph.D.

More on Clinical Trials

DISCOVERY

25:26 23_12_CGPodcast_1280x720_Ep88

Live from ARM's Meeting on the Mesa with Kiji Therapeutics' Dr. Miguel Forte

20:15 21_06_CGPodcast_1200x628_Ep6.2

Gene Therapies For Spinal Cord-Related Disorders With SwanBio's CSO

17:17 23_12_CGPodcast_1280x720_Ep71

Inside Cellular Rejuvenation Therapies for Age-Related Diseases with Life Biosciences' Sharon Rosenzweig-Lipson, Ph.D.

28:15 23_12_CGPodcast_1280x720_Ep100

Rethinking CGT Biotech Growth & Investment with Audrey Greenberg

20:52 23_12_CGPodcast_1280x720_Ep89

Improving TCR T-Cell Persistence and Efficacy with Adaptimmune's Dennis Williams

29:55 23_12_CGPodcast_1280x720_Ep82

Identifying Drug Development Opportunities For DMD With CureDuchenne

21:08 23_12_CGPodcast_1280x720_Ep92

Can Gene Therapy Be The Solution For CHF With AskBio's Dr. Lothar Roessig

26:49 23_12_CGPodcast_1280x720_Ep95

The Future of Adenovector-Based Therapies with Precigen's Helen Sabzevari, Ph.D.

14:53 23_12_CGPodcast_1280x720_Ep99

Advancing Retinal Gene Therapy with Atsena Therapeutics' Dr. Kenji Fujita

27:31 23_12_CGPodcast_1280x720_Ep70

The Future of Rare Diseases with The Jackson Laboratory's Rare Disease Translational Center's Cat Lutz

24:24 23_12_CGPodcast_1280x720_Ep94

The Future of NK Cell Therapy for Autoimmune Disease with Artiva Biotherapeutics' Christopher Horan

38:12 23_12_CGPodcast_1280x720_Ep101

CRI's Response to NIH Cuts with Alicia Zhou, Ph.D.

40:25 21_06_Cell&GeneThePodcast_Video_Ep36

Capstan Therapeutics' CEO Laura Shawver On In Vivo Cell Engineering

21:01 23_12_CGPodcast_1280x720_Ep81

Tackling 'The Delivery Problem' Of Gene Editing-Based Medicines

34:57 23_12_CGPodcast_1280x720_Ep98

Harnessing the Power of Cord Blood Tregs with Cellenkos' Dr. Simrit Parmar

24:34 21_06_Cell&GeneThePodcast_Video_Ep53

Inside Prime Editing With Prime Medicine's Dr. Andrew Anzalone

25:17 21_06_Cell&GeneThePodcast_Video_Ep58

Inside Genome Editing With CBER's Dr. Peter Marks

21:39 23_12_CGPodcast_1280x720_Ep90

Globalization's Impact on Patient Access with ARM's COO, Rita Johnson-Greene

29:16 21_06_Cell&GeneThePodcast_Video_Ep54

The Intersection Of RNA, AI, And Synthetic Biology With Shape Therapeutics' Dr. Francois Vigneault

35:38 23_12_CGPodcast_1280x720_Ep96

Inside Gene Therapies for Cardiac Care with Tenaya Therapeutics' Faraz Ali

35:29 23_12_CGPodcast_1280x720_Ep80

TILs for the Treatment of Solid Tumors with KSQ Therapeutics' Micah Benson, Ph.D.

14:18 23_12_CGPodcast_1280x720_Ep87

Pioneering Next-Gen TCR Therapies In Solid Tumors With Neogene Therapeutics' Carsten Linnemann, Ph.D.

31:14 23_12_CGPodcast_1280x720_Ep91

Inside A Dopamine-Restoring Cell Therapy For PD With BlueRock Therapeutics' Dr. Amit Rakhit

14:52 23_12_CGPodcast_1280x720_Ep78

Developing an mRNA Therapy for DMD with Elixirgen Therapeutics' Aki Ko

More on Discovery

MANUFACTURING

42:20 21_06_Cell&GeneThePodcast_Video_Ep49

TJU's Jefferson Institute for Bioprocessing's Impact on CGT with Parviz Shamlou

28:34 22_01_C&GPodcast_1280x720_ep40

An Interview with Dr. Peter Marks

20:40 21_06_Cell&GeneThePodcast_Video_Ep45

The Potential Of RNA Exon Editing With Ascidian Therapeutics' Romesh Subramanian, Ph.D.

28:35 21_06_Cell&GeneThePodcast_Video_Ep38

The Future Of iPSCs With BlueRock Therapeutics' CEO Seth Ettenberg

21:33 23_12_CGPodcast_1280x720_Ep67

Breaking Down Solid Tumors With Triumvira Immunologics' Dr. Paul Lammers

28:24 21_06_CellGeneThePodcast_Video_Ep29

Best Practices For Partnering With A CDMO

31:57 21_06_Cell&GeneThePodcast_Video_Ep48

Computational Biology's Role In Gene Therapy With Kriya Therapeutics' Dr. Shankar Ramaswamy

37:17 23_12_CGPodcast_1280x720_Ep68

Pricing, Value, And Access of CGTs With The Dedham Group's Jennifer Klarer, M.Sc.Eng.

20:48 23_12_CGPodcast_1280x720_Ep69

Inside Yescarta's Reduced Median Turnaround Time with Kite, a Gilead Company's Christopher McDonald

40:51 21_06_Cell&GeneThePodcast_Video_Ep46

Inside The World's First-Ever Allogeneic Approval With Atara Biotherapeutics' Pascal Touchon

31:48 23_12_CGPodcast_1280x720_Ep76

Dr. Bruce Levine on ISCT and the Future of CAR-T

28:42 23_12_CGPodcast_1280x720_Ep97

CGT Manufacturing: Distributed & Digital with Deloitte Consulting's Omkar Kawalekar, Ph.D.

30:37 21_06_Cell&GeneThePodcast_Video_Ep59

In Vivo CAR T-Cell Therapeutics With Umoja Biopharma's Dr. Andrew Scharenberg

26:34 21_06_Cell&GeneThePodcast_Video_Ep42

2023 Market Outlook with AdBio and ISCT's Miguel Forte

30:23 21_06_CGPodcast_1200x628_Ep2

Hospital Systems & Complex Therapies With University Of Pennsylvania Health System's Kevin Mahoney

27:42 22_07_CellGeneThePodcast_YouTubeThumbnail_ep28

An Interview With Dr. Carl June

27:40 22_01_cgpodcast_1200x628_ep30

A Stem Cell-Derived Treatment For T1D

17:23 21_06_Cell&GeneThePodcast_Video_Ep64

Overcoming The Limitations Of CAR T-Cell Therapy With Vittoria Bio's Nick Siciliano, Ph.D.

26:57 22_01_C&GPodcast_1280x720_Ep39

Inside NK and Macrophage Cellular Immunotherapies

24:15 The Future of Tissue-Based Therapies

The Future of Tissue-Based Therapies

25:55 21_06_CGPodcast_1200x628_Ep4

State-of-the-Art GMP Manufacturing RNA Cell Therapies With Cartesian's CEO

21:42 21_06_Cell&GeneThePodcast_Video_Ep43

The Why Behind In-House Manufacturing With Sangamo's Andy Ramelmeier

31:59 23_12_CGPodcast_1280x720_Ep66

4 Keys To Allo In 2024 With Poseida Therapeutics' Kristin Yarema, Ph.D.

25:53 21_06_Cell&GeneThePodcast_Video_Ep57

The Future Of CAR-T With Bristol Myers Squibb's Lynelle Hoch

31:52 21_06_Cell&GeneThePodcast_Video_Ep44

Automating Processes To Scale CGT Manufacturing With PA Consulting's Paolo Siciliano

28:17 21_06_Cell&GeneThePodcast_Video_Ep47

The Near-Term Future Of Exosome Science With Capricor Therapeutics' Dr. Linda Marbán

32:43 21_06_Cell&GeneThePodcast_Video_Ep33

Inside RNAi With Arrowhead Pharmaceuticals' Javier San Martin

17:45 25_03_CGL_1280x720_Seg01

Cell Therapy's Current Manufacturing Challenges

23:21 21_06_Cell&GeneThePodcast_Video_Ep56

The Promise Of Genome Editing With Caribou Biosciences' Rachel Haurwitz, Ph.D.

22:48 21_06_cell_genethepodcast_video_ep32

Planning For Manufacturing Capacity With Kite Pharma's Will Junker

14:49 23_12_CGPodcast_1280x720_Ep93

Lessons in Automation with Roswell Park Comprehensive Cancer Center's Christopher Choi, Ph.D.

18:15 21_06_Cell&GeneThePodcast_Video_Ep60

The Future Of Cell And Organ Transplantation In Treating T1D With Dr. Camillo Ricordi

19:55 22_01_cgpodcast_1200x628_ep31

Commercialization Learnings With Novartis Gene Therapies' President Chris Fox

28:34 21_06_Cell&GeneThePodcast_Video_Ep62

The Promise Of AAV Gene Therapy With REGENXBIO's Ken Mills

36:45 21_06_Cell&GeneThePodcast_Video_Ep37

Manufacturing at the Point of Care with Orgenesis' CEO Vered Caplan

18:50 22_01_CGPodcast_1200x628_Ep18

Restoration of Immune Balance with Anish Suri, Ph.D., President and CSO at Cue Biopharma

36:05 21_06_Cell&GeneThePodcast_Video_Ep41

CMC And Scale Up With Mustang Bio's Robert Sexton

More on Manufacturing

REGULATORY

27:58 23_12_CGPodcast_1280x720_Ep83

CGT Regulatory Update and Outlook with Dark Horse Consulting's Kimberly Benton, Ph.D.

38:12 23_12_CGPodcast_1280x720_Ep101

CRI's Response to NIH Cuts with Alicia Zhou, Ph.D.

25:21 23_12_CGPodcast_1280x720_Ep77

The Current State of the Global Regulatory Landscape with ISCT's Dr. Bambi Grilley

25:17 21_06_Cell&GeneThePodcast_Video_Ep58

Inside Genome Editing With CBER's Dr. Peter Marks

21:39 23_12_CGPodcast_1280x720_Ep90

Globalization's Impact on Patient Access with ARM's COO, Rita Johnson-Greene

27:37 21_06_Cell&GeneThePodcast_Video_Ep51

Dr. Usman "Oz" Azam Discusses The State Cell And Gene Therapy Space

More on Regulatory